Trademark: 97289101
Word
GLYMAB
Status
Registered
Status Code
700
Status Date
Tuesday, June 27, 2023
Serial Number
97289101
Registration Number
7090280
Registration Date
Tuesday, June 27, 2023
Mark Type
4000
Filing Date
Tuesday, March 1, 2022
Published for Opposition
Tuesday, April 11, 2023

Trademark Owner History
Scancell Limited - Original Registrant

Classifications
5 Pharmaceutical, therapeutic and medicinal preparations and substances to increase the avidity of antibodies for the treatment of cancer; all the foregoing containing monoclonal antibodies; pharmaceutical compounds for the treatment of cancer, all the foregoing containing monoclonal antibodies

Trademark Events
Jun 27, 2023
Notice Of Registration Confirmation Emailed
Jun 27, 2023
Registered-Principal Register
Apr 11, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 11, 2023
Published For Opposition
Mar 22, 2023
Notification Of Notice Of Publication E-Mailed
Mar 8, 2023
Approved For Pub - Principal Register
Mar 8, 2023
Teas/Email Correspondence Entered
Mar 8, 2023
Correspondence Received In Law Office
Mar 6, 2023
Teas Response To Office Action Received
Dec 13, 2022
Notification Of Non-Final Action E-Mailed
Dec 13, 2022
Non-Final Action E-Mailed
Dec 13, 2022
Non-Final Action Written
Dec 13, 2022
Assigned To Examiner
Mar 11, 2022
Preliminary/Voluntary Amendment - Entered
Mar 10, 2022
Assigned To Lie
Mar 9, 2022
Teas Voluntary Amendment Received
Mar 4, 2022
New Application Office Supplied Data Entered
Mar 4, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24